Theriva Biologics TOVX
NYSE TOVX
$0.21 +0.00 (+2.21%)
As of: Oct 21, 2026 · 10:17 AM EDT

Theriva Biologics (TOVX) Current Leases (2010)

Updated

Theriva Biologics' Current Leases came in at $24,400 for Q4 2010.

Analysis

Theriva Biologics (TOVX) Current Leases (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn -
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn -
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn -
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn -
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn -
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn -
10 Theriva Biologics 9.76 Mn -36.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 24,400.00
API Access

Theriva Biologics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=TOVX&period=max&api_key=YOUR_API_KEY